Obsidian Therapeutics
$14.79
2
+$0.27+1.86%Friday 20:00
-$0.07-0.47%Friday 22:27After hours
Statistics
Day High
15.48
Day Low
14.46
52W High
49.97
52W Low
11.52
Volume
167,813
Avg. Volume
-
Mkt Cap
913.62M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Nov 17Expected
Q1 2026
Q2 2026
Next
-1.64
-1.26
-0.89
-0.52
Expected EPS
-0.515625
Actual EPS
N/A
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors. The company's proprietary cytoDRiVE platform is versatile and allows it to leverage drug responsive domains to control protein function, with its initial focus on TIL cell therapies developed from this platform (cytoTILs). The company's flagship product candidate, OBX-115, is a novel, genetically engineered, autologous TIL cell therapy currently in a Phase 2 clinical trial for the treatment of melanoma and a Phase 1 clinical trial for the treatment of non-small cell lung cancer.
Show More
CEO
Madan Jagasia
Employees
87
Country
United States
ISIN
US67448A1060
Listings
0 Comments
Share your thoughts
FAQs
What is Obsidian Therapeutics stock price today?▼
The current price of OBX is $14.79 USD — it has increased by +1.86% in the past 24 hours. Watch Obsidian Therapeutics stock price performance more closely on the chart.
What is Obsidian Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Obsidian Therapeutics stocks are traded under the ticker OBX.
What is Obsidian Therapeutics market cap?▼
Today Obsidian Therapeutics has the market capitalization of 913.62M
When is the next Obsidian Therapeutics earnings date?▼
Obsidian Therapeutics is going to release the next earnings report on November 17, 2026.
What were Obsidian Therapeutics earnings last quarter?▼
OBX earnings for the last quarter are -1.3 USD per share, whereas the estimation was -1.64 USD resulting in a +20.63% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Obsidian Therapeutics have?▼
As of November 1, 2026, the company has 87 employees.
In which sector is Obsidian Therapeutics located?▼
Obsidian Therapeutics operates in the Health & Wellness sector.
When did Obsidian Therapeutics complete a stock split?▼
Obsidian Therapeutics has not had any recent stock splits.
Where is Obsidian Therapeutics headquartered?▼
Obsidian Therapeutics is headquartered in CAMBRIDGE, United States.